Isolation and characterization of antibody fragments selective for toxic oligomeric tau
- 1 March 2015
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 36 (3) , 1342-1355
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging (P30 AG19610)
- NIH grant no. R44AG029777
- NIA (AG029777)
This publication has 96 references indexed in Scilit:
- The Synaptic Accumulation of Hyperphosphorylated Tau Oligomers in Alzheimer Disease Is Associated With Dysfunction of the Ubiquitin-Proteasome SystemThe American Journal of Pathology, 2012
- Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01ACS Chemical Neuroscience, 2012
- Stable Mutated tau441 Transfected SH-SY5Y Cells as Screening Tool for Alzheimer’s Disease Drug CandidatesJournal of Molecular Neuroscience, 2012
- Propagation of Tau Pathology in a Model of Early Alzheimer's DiseaseNeuron, 2012
- Lysine-Specific Molecular Tweezers Are Broad-Spectrum Inhibitors of Assembly and Toxicity of Amyloid ProteinsJournal of the American Chemical Society, 2011
- The Many Faces of TauNeuron, 2011
- Functional Alterations in Memory Networks in Early Alzheimer’s DiseaseNeuroMolecular Medicine, 2010
- Transmission and spreading of tauopathy in transgenic mouse brainNature Cell Biology, 2009
- Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway HypothesisNeuron, 2008
- Isolation of a Human Single Chain Antibody Fragment Against Oligomeric α-Synuclein that Inhibits Aggregation and Prevents α-Synuclein-induced ToxicityJournal of Molecular Biology, 2007